NanoVibronix Rebrands to ENvue Medical, Changes Ticker to FEED
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 12 2025
0mins
Should l Buy ?
Source: Newsfilter
- Company Rebranding: NanoVibronix will change its name to ENvue Medical on December 12, 2025, to better reflect its strategic focus on the ENvue® feeding-tube placement system, marking a new phase defined by precision enteral access and technology-driven growth.
- Ticker Change: On the same day, the company's stock ticker will change to FEED on Nasdaq, aiming to enhance market visibility and attract more investor interest in its new strategic direction.
- Strategic Focus: CEO Doron Besser stated that the company will concentrate on scaling hospital utilization and strengthening its commercial footprint, building a comprehensive enteral-feeding ecosystem through both internal development and external business opportunities to drive future growth.
- Technology Platform Expansion: The ENvue™ Navigation Platform, which has received FDA 510(k) clearance, is designed to assist clinicians in effectively placing feeding tubes, with future expansion potential into pediatric and vascular access applications, further enhancing the company's competitiveness in the medical technology sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
